To test our finding in humans, we examined serum betatrophin levels in 27 patients with T2D who received human insulin (±metformin) treatment and 11 patients who did not receive insulin treatment, but at the same time, matched with age, sex, BMI, blood lipid and metformin use as those received insulin treatment. This evidence concerns the gene ANGPTL8 and type 2 diabetes mellitus.